Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2821 AL 2835

The neuroprotective effects of caffeine in neurodegenerative diseases

Kolahdouzan M, Hamadeh MJ.

CNS Neurosci Ther. 2017 Apr;23(4):272-290. doi: 10.1111/cns.12684.

Biological Basis for Amyloidogenesis in Alzheimer's Disease

Andreeva TV, Lukiw WJ, Rogaev EI.

Biochemistry (Mosc). 2017 Feb;82(2):122-139. doi: 10.1134/S0006297917020043.

Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial

Gelderblom H, Wüstenberg T, McLean T, Mütze L, Fischer W, Saft C, Hoffmann R, Süssmuth S, Schlattmann P, van Duijn E, Landwehrmeyer B, Priller J.

PLoS One. 2017 Mar 21;12(3):e0173872. doi: 10.1371/journal.pone.0173872. eCollection 2017.

Huntington's Disease-Update on Treatments

Wyant KJ, Ridder AJ, Dayalu P.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):33. doi: 10.1007/s11910-017-0739-9.

Neuronal Mitophagy in Neurodegenerative Diseases

Martinez-Vicente M.

Front Mol Neurosci. 2017 Mar 8;10:64. doi: 10.3389/fnmol.2017.00064. eCollection 2017.

A Systematic Review of the Huntington Disease-Like 2 Phenotype

Anderson DG, Walker RH, Connor M, Carr J, Margolis RL, Krause A.

J Huntingtons Dis. 2017;6(1):37-46. doi: 10.3233/JHD-160232.

Is Huntingtin Dispensable in the Adult Brain?

Liu JP, Zeitlin SO.

J Huntingtons Dis. 2017;6(1):1-17. doi: 10.3233/JHD-170235.

Feasibility and Efficacy of Brief Computerized Training to Improve Emotion Recognition in Premanifest and Early-Symptomatic Huntington's Disease

Kempnich CL, Wong D, Georgiou-Karistianis N, Stout JC.

J Int Neuropsychol Soc. 2017 Apr;23(4):314-321. doi: 10.1017/S1355617717000145. Epub 2017 Mar 30.

Instruments measuring the disease-specific quality of life of family carers of people with neurodegenerative diseases: a systematic review

Page TE, Farina N, Brown A, Daley S, Bowling A, Basset T, Livingston G, Knapp M, Murray J, Banerjee S.

BMJ Open. 2017 Mar 29;7(3):e013611. doi: 10.1136/bmjopen-2016-013611.

The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone

Motamedi S, Karimi I, Jafari F.

Metab Brain Dis. 2017 Jun;32(3):651-665. doi: 10.1007/s11011-017-9997-0. Epub 2017 Mar 30.

Physical Activity Self-Management and Coaching Compared to Social Interaction in Huntington Disease: Results From the ENGAGE-HD Randomized, Controlled Pilot Feasibility Trial

Busse M, Quinn L, Drew C, Kelson M, Trubey R, McEwan K, Jones C, Townson J, Dawes H, Tudor-Edwards R, Rosser A, Hood K.

Phys Ther. 2017 Jun 1;97(6):625-639. doi: 10.1093/ptj/pzx031.

Anti-Yo, chorea and hemiballismus: A case report

Goldstein L, Djaldetti R, Benninger F.

J Clin Neurosci. 2017 Aug;42:113-114. doi: 10.1016/j.jocn.2017.03.045. Epub 2017 Mar 31.

Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington's disease

Tyebji S, Hannan AJ.

Prog Neurobiol. 2017 Jun;153:18-45. doi: 10.1016/j.pneurobio.2017.03.008. Epub 2017 Apr 2.

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases

Gao J, Wang L, Liu J, Xie F, Su B, Wang X.

Antioxidants (Basel). 2017 Apr 5;6(2):25. doi: 10.3390/antiox6020025.

Autophagic flux control in neurodegeneration: Progress and precision targeting-Where do we stand?

Lumkwana D, du Toit A, Kinnear C, Loos B.

Prog Neurobiol. 2017 Jun;153:64-85. doi: 10.1016/j.pneurobio.2017.03.006. Epub 2017 Apr 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias